Orbimed Advisors LLC Genfit S.A. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$14.92 - $19.94 $16.8 Million - $22.4 Million
-1,125,607 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$19.74 - $25.65 $2.07 Million - $2.69 Million
-104,707 Reduced 8.51%
1,125,607 $22.2 Million
Q1 2019

May 15, 2019
BUY
$22.17 - $24.0 $27.3 Million - $29.5 Million
1,230,314 New
1,230,314 $29.5 Million

Others Institutions Holding GNFT

# of Institutions
5
Shares Held
77.7K
Call Options Held
0
Put Options Held
0
View Full List

About Genfit S.A.

GNFT Quotes by TradingView
  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $185M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email